iPSC-Derived Immunotherapies Congress

    iPSC-Derived Immunotherapies Congress, on 18-19 October 2022 in Boston will highlight techniques used to develop safe, differentiated, and efficacious therapies to pass through regulatory hurdles. This event will be your opportunity to analyze developments in bringing iPSC-derived immunotherapies from bench to bedside to deliver long-lasting, safe, effective therapeutics.

    Create a clear roadmap for clinical success with insights from industry leaders with advanced pipelines
    Ensure durability and avoid immune rejection through effective next-generation gene editing strategies
    Accelerate your IPSC-derived cell therapy manufacturing by establishing an automated, regulatory compliant manufacturing workflow
    Effectively navigate the regulatory requirements to bring IPSC-derived therapies into clinical trials with accelerated IND submission

    Event Venue: Boston, Massachusetts
    Event Date: 18-19 October, 2022
    Event website: https://hubs.ly/Q01j6Hyk0
    Event Organizer: Kisaco Research
    Contact number: +44 (0)20 3696 2920
    Email ID: marketing@kisacoresearch.com

    Organiser: Kisaco Research

    Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively.

    Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Our platforms are neutral, so that our attendees get the right information from the most relevant people.